We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

644 hedge funds and large institutions have $13.5B invested in Charles River Laboratories in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 262 increasing their positions, 235 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 235

0.8% more ownership

Funds ownership: 93.47% → 94.28% (+0.8%)

1% less call options, than puts

Call options by funds: $77.7M | Put options by funds: $78.4M

9% less funds holding

Funds holding: 707 → 644 (-63)

24% less capital invested

Capital invested by funds: $17.7B → $13.5B (-$4.23B)

48% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 115

53% less funds holding in top 10

Funds holding in top 10: 15 → 7 (-8)

Holders
644
Holders Change
-63
Holders Change %
-8.91%
% of All Funds
10.16%
Holding in Top 10
7
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-53.33%
% of All Funds
0.11%
New
60
Increased
262
Reduced
235
Closed
115
Calls
$77.7M
Puts
$78.4M
Net Calls
-$664K
Net Calls Change
-$48.1M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$171M
2
ClearBridge Investments
ClearBridge Investments
New York
+$92.9M
3
Fidelity International
Fidelity International
Bermuda
+$83.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$53.3M
5
JMPWA
JP Morgan Private Wealth Advisors
California
+$47M

Top Sellers

1
Invesco
Invesco
Georgia
-$142M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$118M
3
Brown Advisory
Brown Advisory
Maryland
-$111M
4
Marshall Wace
Marshall Wace
United Kingdom
-$86.9M
5
ESCM
Echo Street Capital Management
New York
-$65.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
201
Kennedy Capital Management
Missouri
$4.4M +$305K +989 +7%
AIG
202
American International Group
New York
$4.38M -$119K -385 -2%
WT
203
Whittier Trust
California
$4.37M +$348K +1,128 +8%
DekaBank Deutsche Girozentrale
204
DekaBank Deutsche Girozentrale
Germany
$4.34M +$204K +663 +5%
FHB
205
First Hawaiian Bank
Hawaii
$4.28M -$42.2K -137 -0.9%
GC
206
Guggenheim Capital
Illinois
$4.24M -$1.17M -3,807 -20%
Janus Henderson Group
207
Janus Henderson Group
United Kingdom
$4.17M +$2.6M +8,421 +135%
MAM
208
Mastrapasqua Asset Management
Tennessee
$4.07M -$229K -742 -5%
ECM
209
EagleClaw Capital Management
Massachusetts
$4.01M +$3.13M +10,135 +254%
ASRS
210
Arizona State Retirement System
Arizona
$3.99M +$100K +325 +2%
BCM
211
Brown Capital Management
Maryland
$3.98M +$123K +399 +3%
KA
212
Kerrisdale Advisers
Florida
$3.97M -$18.6M -60,281 -81%
ERSOT
213
Employees Retirement System of Texas
Texas
$3.89M – – –
TPCW
214
TD Private Client Wealth
New York
$3.87M +$428K +1,389 +11%
Teacher Retirement System of Texas
215
Teacher Retirement System of Texas
Texas
$3.86M +$962K +3,121 +30%
RI
216
Redwood Investments
Massachusetts
$3.75M +$6.17K +20 +0.2%
FA
217
FDx Advisors
Illinois
$3.69M +$109K +355 +3%
SOMRS
218
State of Michigan Retirement System
Michigan
$3.62M +$9.25K +30 +0.2%
Adage Capital Partners
219
Adage Capital Partners
Massachusetts
$3.61M -$12.7M -41,100 -76%
Aberdeen Group
220
Aberdeen Group
United Kingdom
$3.59M -$724K -2,348 -16%
GF
221
Gabelli Funds
New York
$3.55M +$2.16M +7,000 +127%
Tudor Investment Corp
222
Tudor Investment Corp
Connecticut
$3.54M +$331K +1,075 +9%
EVM
223
Eaton Vance Management
Massachusetts
$3.48M -$34M -110,390 -90%
OPERF
224
Oregon Public Employees Retirement Fund
Oregon
$3.46M +$20.4K +66 +0.5%
Zurich Cantonal Bank
225
Zurich Cantonal Bank
Switzerland
$3.38M +$385K +1,250 +12%
7 8
9
10 11

CRL Hedge Fund Activity: Q1 2022 in Review

644 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2022, worth a combined $13.5B — down 24% from $17.7B a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of CRL and 60 opened new positions — a net loss of 55 holders — while 235 trimmed existing stakes and 262 added.

The largest buyer was Mackenzie Financial, adding an estimated $171M. The largest seller was Invesco, cutting an estimated $142M.

  • 644 institutional investors held Charles River Laboratories (CRL) as of Q1 2022, down from 707 in Q4 2021.
  • Funds reported $13.5B of Charles River Laboratories stock for Q1 2022, down 24% quarter-over-quarter.
  • 60 funds opened new Charles River Laboratories positions in Q1 2022 and 115 closed out, a net change of -55 holders.
  • The largest Charles River Laboratories buyer in Q1 2022 was Mackenzie Financial, an estimated $171M added.
  • The largest Charles River Laboratories seller in Q1 2022 was Invesco, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2022.